Quantification of Acylfulvene– and Illudin S–DNA Adducts in Cells with Variable Bioactivation Capacities
- 19 December 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 26 (1) , 146-155
Abstract
Illudin S and its semisynthetic analogue acylfulvene (AF) are structurally similar but elicit different biological responses. AF is a bioreductive alkylating anticancer agent with a favorable therapeutic index, while illudin S is in general highly toxic. AF toxicity is dependent on the reductase enzyme prostaglandin reductase 1 (PTGR1) for activation to a cytotoxic reactive intermediate. While illudin S can be metabolized by PTGR1, available data suggest that its toxicity does not correspond with PTGR1 function. The goal of this study was to understand how drug cytotoxicity relates to cellular bioactivation capacity and the identity and quantity of AF– or illudin S–DNA adducts. The strategy involved identification of novel illudin S–DNA adducts and their quantitation in a newly engineered SW-480 colon cancer cell line that stably overexpresses PTGR1 (PTGR1-480). These data were compared with cytotoxicity data for both compounds in PTGR1-480 versus normal SW-480 cells, demonstrating that AF forms more DNA adducts and is more cytotoxic in cells with higher levels of PTGR1, whereas illudin S cytotoxicity and adduct formation are not influenced by PTGR1 levels. Results are discussed in the context of an overall model for how changes in relative propensities of these compounds to undergo cellular processes, such as bioactivation, contributes to DNA damage, and cytotoxicity.Keywords
This publication has 28 references indexed in Scilit:
- Chemical and Enzymatic Reductive Activation of Acylfulvene to Isomeric Cytotoxic Reactive IntermediatesChemical Research in Toxicology, 2011
- Increased Selectivity, Analytical Precision, and Throughput in Targeted ProteomicsMolecular & Cellular Proteomics, 2011
- Structure−Activity Studies of Urea, Carbamate, and Sulfonamide Derivatives of AcylfulveneJournal of Medicinal Chemistry, 2010
- Screening for DNA Adducts by Data-Dependent Constant Neutral Loss-Triple Stage Mass Spectrometry with a Linear Quadrupole Ion Trap Mass SpectrometerAnalytical Chemistry, 2008
- Investigating the Role of Stereochemistry in the Activity of Anticancer Acylfulvenes: Synthesis, Reductase-Mediated Bioactivation, and Cellular ToxicityJournal of Medicinal Chemistry, 2006
- Isolation of Illudin S from the Mature Basidiocarp ofOmphalotus Illudens, and Isolation of Illudins S and M from the Fermentation Broth ofOmphalotus OlearisNatural Product Letters, 1996
- Acylfulvenes, a new class of potent antitumor agentsCellular and Molecular Life Sciences, 1996
- Michael-Type Addition of Illudin S, a Toxic Substance from Lampteromyces japonicus, with Cysteine and Cysteine-Containing Peptides in Vitro.Chemical and Pharmaceutical Bulletin, 1996
- Molecular biomarkers for human chemical carcinogen exposuresChemical Research in Toxicology, 1993
- Metabolism of illudin S, a toxic principle ofLampteromyces japonicus, by rat liver. I. Isolation and identification of cyclopropane ring-cleavage metabolitesXenobiotica, 1990